Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v24-FR Version v23-EN
Language French English
Date Updated 2018-11-07 2018-11-07
Drug Identification Number 00358177 00358177
Brand name MAXITROL MAXITROL
Common or Proper name MAXITROL OINT 3.5G MAXITROL OINT 3.5G
Company Name NOVARTIS PHARMACEUTICALS CANADA INC NOVARTIS PHARMACEUTICALS CANADA INC
Ingredients DEXAMETHASONE POLYMYXIN B SULFATE NEOMYCIN DEXAMETHASONE POLYMYXIN B SULFATE NEOMYCIN
Strength(s) 1MG 6000UNIT 3.5MG 1MG 6000UNIT 3.5MG
Dosage form(s) OINTMENT OINTMENT
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 3.5G 3.5G
ATC code S01CA S01CA
ATC description ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2018-06-14 2018-06-14
Estimated end date 2018-11-06 2018-11-06
Actual end date 2018-11-06 2018-11-06
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments Stock is available for MAXITROL SUSPENSION 5ML (#742653) Stock is available for MAXITROL SUSPENSION 5ML (#742653)
Health Canada comments